Navigation Links
US Female Sterilization Market to Grow to Almost $245 Million Over the Next Five Years
Date:4/30/2008

Increasing transcervical female sterilization procedures to drive the US

gynecological market, according to Millennium Research Group

WALTHAM, Mass., April 30 /PRNewswire/ -- According to Millennium Research Group's (MRG) US Markets for Gynecological Devices 2008 report, the female sterilization market was worth over $80 million in 2007. Driven by increasing demand for transcervical procedures, this market is expected to grow to almost $245 million by 2012.

Currently, Conceptus is the only player in the transcervical sterilization device market; however, MRG estimates Hologic to launch Adiana, its new female sterilization product, in 2009. Through 2012, growth in the number of doctors performing transcervical sterilization procedures, particularly those operating in an office setting, will fuel market expansion.

"In 2007, growth in the US female sterilization market came from the rapidly expanding transcervical sterilization device market, while both the mechanical and bipolar sterilization device markets declined from 2006," says Barbara Prud'homme, Senior Analyst at Millennium Research Group. "Over the next five years, this trend will continue as transcervical sterilization becomes the standard of care for female sterilization procedures in the US market."

Direct-to-consumer advertising by Conceptus, using TV, radio, online, and print media, will further raise awareness of transcervical sterilization procedures. As more potential patients become aware of transcervical sterilization, demand for the procedure will increase, boosting unit sales.

The US Markets for Gynecological Devices 2008 report provides coverage of all key industry competitors, including Hologic, Gynecare, Conceptus, Boston Scientific, Cooper Surgical, and American Medical Systems. Other regions covered in this global series include Europe (France, Germany, Italy, and the UK).

About Transcervical Female Sterilization

Transcervical female sterilization refers to sterilization methods that involve reaching the fallopian tubes through the vagina and uterus. Transcervical female sterilization provides women with a minimally invasive permanent sterilization option that does not involve external scarring or the use of drugs or hormones to prevent pregnancy. This procedure can be performed in a gynecologist's office, with the patient able to return home the same day and resume normal activities within a short period of time.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Females avoid incest by causing male relatives to leave home
2. Gene Studies of Male-Female Differences Often Flawed
3. Struggling male readers respond better to female teachers
4. More sick leave given to men by male GPs compared with female counterparts
5. Researchers discover correlation between GERD and obesity in females
6. Most patients who have male-to-female sex-change surgery are happy, despite complications
7. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
8. Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients
9. Female Blood Donor Concern May Be Unfounded
10. Some Female Athletes Risking Weaker Bones
11. The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , The healthcare industry in the United States has undergone major changes over the ... needing to have a doctor’s order to get a blood test or other lab ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... ... ... Chain”: an inspirational story for those shackled by the chains of a broken life. ... writer and a woman of great faith and wisdom. She is a great motivational ... born and raised in Vero Beach, Florida and has dedicated her life and ministry to ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... of disease. It’s reaching out to a patient who feels isolated. It’s developing ... amid madness. , WesternU President Daniel R. Wilson, MD, PhD, invited three renowned ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
(Date:8/3/2017)... -- Opioid addiction and other drugs of abuse, blood poisoning ... outcomes, were problems taken on directly as laboratory professionals, ... them, met this week. This according to Kalorama Information. ... abuse, procalcitonin and acute kidney injury were key focuses ... in San Diego, CA.  Mechanisms ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
Breaking Medicine Technology: